Estimation of the economic impact of ambulatory dialysis in France: The case of continuous peritoneal dialysis

被引:0
作者
Lebrun, T [1 ]
Marissal, JP [1 ]
Sailly, JC [1 ]
机构
[1] CRESGE, F-59016 Lille, France
来源
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE | 1997年 / 45卷 / 06期
关键词
cost; renal failure; dialysis; peritoneal dialysis;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Backgrounds: As concerns the treatment of terminal renal failure (TRF), France is characterized by a minimal use of peritoneal dialysis, even though this technique is as effective and less expensive than others and that authorities preconize to switch patients to out-of-centre techniques, like peritoneal dialysis. The purpose of the article is to estimate benefits for the Social Security induced by an incitative program leading the current structure of TRF treatment to the existing government standards defined in 1984. Method: We computed treatment cost differences, on the basis of an incident case of TRF followed during 7 years, between three different situations : the current French structure of TRF treatment (29.5% of patients treated by out-of-center techniques); two reference situations A and B (respectively 45% and 37% of patients treated by out-of-center techniques). We performed a sensitivity analysis on the rate of use of continuous ambulatory peritoneal dialysis (CAPD). We made assumptions on the cost of techniques, the cost of complications and the rate of CAPD treatment failure. Results: Results stress the existence of benefits induced by increased use of out-of-centre techniques on the basis of a 7-year follow-up of an incident TRF patient : around 65,000 FF in situation A with a 20% rate of use of CAPD; around 5,000 FF in situation B with a 15% rate of use of CAPD. Assumptions concerning CARD treatment lead to an underestimation of the true benefits. Conclusion: The study highlights the therapeutic and economic interest to transfer some patients from hemodialysis so peritoneal dialysis.
引用
收藏
页码:493 / 507
页数:15
相关论文
共 26 条
  • [1] AUBOURG E, 1992, RAPPORT INSPECTION G, V1
  • [2] BONAN H, 1994, ENQUETE DIALYSE RENA
  • [3] CHANUT C, 1991, REV EPIDEMIOL SANTE, V39, P353
  • [4] DUBOIS JP, 1995, NEPHROLOGIE, V16, P145
  • [5] RENAL REPLACEMENT THERAPY IN CANADA - A REPORT FROM THE CANADIAN ORGAN REPLACEMENT REGISTER
    FENTON, S
    DESMEULES, M
    COPLESTON, P
    ARBUS, G
    FROMENT, D
    JEFFERY, J
    KJELLSTRAND, C
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (01) : 134 - 150
  • [6] FIEVET P, 1995, PROJET INTEGRATION T
  • [7] Freida P, 1995, B DIAL PERIT, V5, P7
  • [8] IS CAPD OR HEMODIALYSIS BETTER FOR DIABETIC-PATIENTS - HEMODIALYSIS IS SUPERIOR
    FRIEDMAN, EA
    [J]. SEMINARS IN DIALYSIS, 1992, 5 (03) : 176 - 181
  • [9] CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND HEMODIALYSIS - COMPARISON OF PATIENT MORTALITY WITH ADJUSTMENT FOR COMORBID CONDITIONS
    HELD, PJ
    PORT, FK
    TURENNE, MN
    GAYLIN, DS
    HAMBURGER, RJ
    WOLFE, RA
    [J]. KIDNEY INTERNATIONAL, 1994, 45 (04) : 1163 - 1169
  • [10] A COMPARISON OF EMPLOYMENT RATES OF PATIENTS TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS VS IN-CENTER HEMODIALYSIS (MICHIGAN END-STAGE RENAL-DISEASE STUDY)
    JULIUS, M
    KNEISLEY, JD
    CARPENTIERALTING, P
    HAWTHORNE, VM
    WOLFE, RA
    PORT, FK
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (04) : 839 - 842